Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

Irene M. Ghobrial; Wanling Xie; Swaminathan Padmanabhan; Ashraf Badros; Meghan Rourke; Renee Leduc; Stacey Chuma; Janet Kunsman; Diane Warren; Tiffany Poon; Brianna Harris; Amy Sam; Kenneth C. Anderson; Paul G. Richardson; Steven P. Treon; Edie Weller; Jeffrey Matous

doi:10.1002/AJH.21788

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

Irene M. Ghobrial
, Wanling Xie
, Swaminathan Padmanabhan
, Ashraf Badros
, Meghan Rourke
, Renee Leduc
, Stacey Chuma
, Janet Kunsman
, Diane Warren
, Tiffany Poon
, Brianna Harris
, Amy Sam
, Kenneth C. Anderson
, Paul G. Richardson
, Steven P. Treon
, Edie Weller
, Jeffrey Matous

Harvard University
Roswell Park Cancer Institute
University of Maryland, College Park
Rocky Mountain Cancer Center, Denver, Colorado.

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	American Journal of Hematology
Volume	85
Issue number	9
DOIs	https://doi.org/10.1002/AJH.21788
State	Published - Sep 1 2010
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Surgery
Internal Medicine

Access to Document

10.1002/AJH.21788License: Unspecified

Cite this

Ghobrial, I. M., Xie, W., Padmanabhan, S., Badros, A., Rourke, M., Leduc, R., Chuma, S., Kunsman, J., Warren, D., Poon, T., Harris, B., Sam, A., Anderson, K. C., Richardson, P. G., Treon, S. P., Weller, E., & Matous, J. (2010). Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia. American Journal of Hematology, 85(9). https://doi.org/10.1002/AJH.21788

Ghobrial, IM, Xie, W, Padmanabhan, S, Badros, A, Rourke, M, Leduc, R, Chuma, S, Kunsman, J, Warren, D, Poon, T, Harris, B, Sam, A, Anderson, KC, Richardson, PG, Treon, SP, Weller, E & Matous, J 2010, 'Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.', American Journal of Hematology, vol. 85, no. 9. https://doi.org/10.1002/AJH.21788

@article{084c3f90111e4bb8b8b0ae499a15f985,

title = "Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenstr{\"o}m Macroglobulinemia.",

author = "Ghobrial, \{Irene M.\} and Wanling Xie and Swaminathan Padmanabhan and Ashraf Badros and Meghan Rourke and Renee Leduc and Stacey Chuma and Janet Kunsman and Diane Warren and Tiffany Poon and Brianna Harris and Amy Sam and Anderson, \{Kenneth C.\} and Richardson, \{Paul G.\} and Treon, \{Steven P.\} and Edie Weller and Jeffrey Matous",

year = "2010",

month = sep,

day = "1",

doi = "10.1002/AJH.21788",

language = "American English",

volume = "85",

journal = "American Journal of Hematology",

issn = "1096-8652",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

AU - Ghobrial, Irene M.

AU - Xie, Wanling

AU - Padmanabhan, Swaminathan

AU - Badros, Ashraf

AU - Rourke, Meghan

AU - Leduc, Renee

AU - Chuma, Stacey

AU - Kunsman, Janet

AU - Warren, Diane

AU - Poon, Tiffany

AU - Harris, Brianna

AU - Sam, Amy

AU - Anderson, Kenneth C.

AU - Richardson, Paul G.

AU - Treon, Steven P.

AU - Weller, Edie

AU - Matous, Jeffrey

PY - 2010/9/1

Y1 - 2010/9/1

UR - https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.21788

U2 - 10.1002/AJH.21788

DO - 10.1002/AJH.21788

M3 - Article

SN - 1096-8652

VL - 85

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 9

ER -

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

Disciplines

Access to Document

Other files and links

Cite this